Interchange Capital Partners’s Labcorp LH Stock Holding History

Interchange Capital Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-44	Closed	-$7K	–	716
2020 Q4	$7K	Buy	+44	New	+$7.6K	﹤0.01%	858

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Interchange Capital Partners's LH Position: Q1 2021 in Review

Interchange Capital Partners sold out of Labcorp (LH) in Q1 2021, closing a stake of 44 shares — an estimated $7K sold.

Interchange Capital Partners first reported a position in LH in Q4 2020 and held it in 1 quarter. The position peaked at $7K in Q4 2020. 920 funds tracked by Wall St. Rank hold LH as of Q1 2021.

Interchange Capital Partners reported no remaining Labcorp position as of Q1 2021 after selling out during the quarter.
Interchange Capital Partners sold 44 Labcorp shares in Q1 2021, an estimated $7K.
Interchange Capital Partners first reported a position in Labcorp in Q4 2020 and held it in 1 quarter.
Interchange Capital Partners's Labcorp position peaked at $7K in Q4 2020.
920 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.